FDA grants traditional approval for pembrolizumab in TMB-H solid tumors

The FDA granted traditional approval for pembrolizumab, or pembrolizumab and berahyaluronidase alfa-pmph, for unresectable or metastatic TMB-H solid tumors with an updated indication.

Detected & updated continuously · Source: Nebula